Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions

E-ISSN： 1873-4294|15|21|2139-2151

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.15, Iss.21, 2015-01, pp. : 2139-2151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy

By O'Regan Ruth Hawk Natalyn Nicole

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 859-872

Informa Healthcare

Access to resources Recommend Favorite

mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma

Current Cancer Drug Targets, Vol. 12, Iss. 9, 2012-11 ,pp. : 1045-1061

Bentham Science Publishers

Access to resources Recommend Favorite

The Applicability of mTOR Inhibition in Solid Tumors

Current Cancer Drug Targets, Vol. 9, Iss. 3, 2009-05 ,pp. : 439-450

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR Inhibition in Lymphoma: A Rational and Promising Strategy

Letters in Drug Design & Discovery, Vol. 4, Iss. 3, 2007-04 ,pp. : 224-231

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1710-1719

Bentham Science Publishers

Access to resources Recommend Favorite